ResMed Inc. RMD
222.00
0.11
0.05%
as of 25 Sep
- Market cap
- $31.9B
- P/E
- 21.3×
Follow RMD
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
ResMed Inc. (RMD) Book value per share
ResMed Inc.'s book value per share at the end of fiscal 2026 was 45.3×, up 11.3% from 40.7× in fiscal 2025. Over the past ten years it has ranged from 11.3× (fiscal 2015) to 45.3× (fiscal 2026) — the current reading is the highest in ten years. ResMed Inc. ranks 6th of 56 Medical Instruments & Supplies companies by book value per share.
Book value per share, annual
Annual
| Period | Book value per share | Change |
|---|---|---|
| FY2026 | 45.3× | 11.25% |
| FY2025 | 40.7× | 22.95% |
| FY2024 | 33.1× | 17.57% |
| FY2023 | 28.1× | 22.30% |
| FY2022 | 23.0× | 15.86% |
| FY2021 | 19.9× | 14.79% |
| FY2020 | 17.3× | 19.48% |
| FY2019 | 14.5× | 0.40% |
| FY2018 | 14.4× | 4.00% |
| FY2017 | 13.9× | 14.75% |
Quarterly
| Period | Book value per share | Change |
|---|---|---|
| Jun 2026 | 45.3× | 1.31% |
| Mar 2026 | 44.7× | 3.06% |
| Dec 2025 | 43.3× | 3.50% |
| Sep 2025 | 41.9× | 2.95% |
| 42 more quarters | Free account |
Against its own ten years
Low 11.3×
High 45.3×
Ten-year median
18.6×
Current reading's percentile
100
Book value per share against peers
| Company | Book value per share |
|---|---|
| BDX Becton, Dickinson and Company compare | 88.9× |
| RMD ResMed Inc. | 45.3× |
| ALC Alcon compare | 44.4× |
| COO The Cooper Companies, Inc. compare | 43.2× |
| WST West Pharmaceutical Services, Inc. compare | 42.2× |
| RGEN Repligen Corporation compare | 37.4× |
| SOLV Solventum Corporation compare | 27.8× |
| MDLN Medline Inc. compare | 22.3× |
| BAX Baxter International Inc. compare | 12.0× |
What Book value per share is
BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.
(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))
More on RMD
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Revenue growth
- The full statement